Related Experiment Video
Updated: Jan 28, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways
Haowei Liu1, Juan Wang2, Yexing Tao3
1College of Pharmacy, Guilin Medical University, 541004 Guilin, China.
Aims:
The purpose of this study was to demonstrate how curcumol affected the expression of miR-21 and whether its effects on miR-21 was associated with the activation of PTEN/PI3K/Akt pathways in CRC cells.
Main Methods:
MTT and xenograft assay were used to examine how curcumol inhibits colorectal cancer (CRC) cells' growth. Q-PCR and western blot analysis were employed to test the role of miR-21 in the inhibition of curcumol on proliferation and PTEN/PI3K/Akt pathways of CRC cells.
Key Findings:
We found that curcumol effectively inhibited CRC cells from proliferating via the PTEN/PI3K/Akt pathways and reduced expression of miR-21 both in vitro and in vivo. miR-21 mimics were found to decrease the protein level of PTEN and increase the expression of PI3K, phospho-Akt (p-Akt) and NF-κB, while miR-21 sponge (miR-21-SP) enhanced the expression of PTEN and reduced the activity of PI3K, Akt and NF-κB. Furthermore, miR-21-SP strengthened the role of curcumol in up-regulating PTEN and inhibiting PI3K/Akt pathways, but miR-21 reversed the effect of curcumol on the PTEN/PI3K/Akt pathways.
Significance:
Our research demonstrated that curcumol reduced the proliferation of CRC cells through PTEN/PI3K/Akt by targeting miR-21 and miR-21 could be a target molecule of curcumol for CRC treatment.
Insights
Curcumol inhibits colorectal cancer (CRC) cell proliferation by targeting microRNA-21 (miR-21) and modulating the PTEN/PI3K/Akt pathway. This study highlights miR-21 as a potential therapeutic target for CRC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Colorectal cancer (CRC) remains a significant health challenge.
- Targeting specific molecular pathways offers potential therapeutic strategies.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
Purpose of the Study:
- To investigate the effect of curcumol on miR-21 expression in CRC cells.
- To determine if curcumol's impact on miR-21 is linked to the PTEN/PI3K/Akt signaling pathway.
- To explore the therapeutic potential of curcumol in CRC treatment.
Main Methods:
- Cell proliferation was assessed using MTT assays.
- In vivo efficacy was evaluated through xenograft assays.
- Quantitative PCR (Q-PCR) and Western blot analysis were used to measure gene and protein expression, including miR-21, PTEN, PI3K, and Akt.
Main Results:
- Curcumol significantly inhibited CRC cell proliferation both in vitro and in vivo.
- Curcumol treatment led to reduced miR-21 expression.
- Modulation of miR-21 levels affected PTEN expression and the activity of the PI3K/Akt pathway, influencing curcumol's therapeutic effects.
Conclusions:
- Curcumol suppresses CRC cell proliferation by targeting miR-21 and influencing the PTEN/PI3K/Akt pathway.
- miR-21 emerges as a key mediator in curcumol's anti-cancer activity.
- These findings suggest that curcumol, by targeting miR-21, holds promise as a therapeutic agent for colorectal cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Feedback Inhibition
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Enzyme Inhibition

